Do the newest grafts achieve comparable results to saphenous vein bypass? THE HEPARIN-BONDED eptfe GRAFT. C. Pratesi
|
|
|
- Buck Hood
- 5 years ago
- Views:
Transcription
1 Do the newest grafts achieve comparable results to saphenous vein bypass? THE HEPARIN-BONDED eptfe GRAFT C. Pratesi Department of Vascular Surgery University of Florence-Italy
2 FEMORO-POPLITEAL DISEASE: treatment options ENDOVASCULAR OPEN SURGERY
3 Overall, there was no significant difference in AFS or OS between the two strategies. However, for those patients who survived for at least 2 years after randomization, a BSX-first revascularization strategy was associated with a significant increase in subsequent OS and a trend towards improved AFS. Bradbury, J Vasc Surg 2010
4 FEMORAL-POPLITEAL BYPASS: factors affecting outcomes Clinical presentation Distal anastomosis Graft material Outflow vessels TASC-2 Guidelines, J Vasc Surg 2007
5 The great saphenous vein performs better than polytetrafluoroethylene in femoropopliteal bypass grafting and should be used whenever possible. However, the absence of a suitable saphenous remains an acceptable indication for a femoropopliteal bypass in PTFE. Pereira CE, J Vasc Surg 2006
6 An adequate caliber, good quality great saphenous vein (GSV) is the optimal graft for distal bypass in the leg. The availability of such a conduit is a relevant limitation of lower extremity bypass surgery: good ipsilateral greater saphenous vein may be lacking in up to 40% of the patients. The strong relationship between vein diameter and graft failure makes autologous saphenous vein unsuitable in some 25% of the patients with critical limb ischemia. Conte MS, J Vasc Surg 2010
7 GRAFT MATERIAL: How to improve eptfe graft outcomes? Morphological modifications (i.e. distal cuff) Biochemical modifications (carbon impregnated or heparin bonded grafts)
8 GRAFT MATERIALS Heparin-bonded graft Recently an eptfe prosthetic graft with covalent end-point attachment of heparin to graft surface (CBAS) has been introduced, enabling maintenance of functional heparin bioactivity Supposed advantages LOWERING THE RATES OF EARLY GRAFT THROMBOSIS REDUCTION OF EARLY REINTERVENTIONS IMPROVING LONG TERM PATENCY RATES
9 The Hb-PTFE graft significantly reduced the overall risk of primary graft failure by 37%. Risk reduction was 50% in femoro-popliteal bypass cases and in cases with critical ischaemia. (Eur J Vasc Endovasc Surg 2011)
10 Italian Propaten Registry To evaluate early and long term results of the use of a heparin-bonded eptfe graft in patients undergoing surgical treatment for PAD. Choice of the graft at the surgeon s discretion and not only in the absence of a suitable vein. Endpoints: early graft thromboses and amputations primary, secondary patency and limb salvage rate during follow-up analysis and comparison in subgroups
11 Centres Involved Università dell Insubria - Varese Patrizio Castelli Ospedale di Mestre Vittorio Dorrucci Università di Firenze Carlo Pratesi Ospedale di Avezzano (AQ) Giovanni De Blasis Ospedale di Catania Vincenzo Monaca Ospedale di Reggio Emilia Enrico Vecchiati Ospedale di Terni Fiore Ferilli
12 Italian Propaten Registry
13 External validation obtained
14 ITALIAN REGISTRY Patients with Critical Limb Ischemia 476 HePTFE below-knee bypasses 385 ASV below-knee bypasses
15 Comparison with autologous saphenous vein bypass in CLI Patient characteristics HePTFE ASV p (476 cases) (385 cases) Female gender 108 (22.5%) 98 (25.5%) 0.3 Diabetes 227 (47.5%) 173 (45)% 0.4 Hypertension 426 (89%) 328 (85%) 0.07 Hyperlipemia 285 (60%) 194 (50%) Renal failure 73 (15%) 53 (14%) 0.5 Coronary disease 227 (48%) 134 (35%) < 0.001
16 Comparison with autologous saphenous vein bypass in CLI Patient characteristics Rutherford s 5-6 HePTFE ASV p (476 cases) (385 cases) 232 (49%) 181 (47%) 0.6 Redo surgery 138 (29%) 77 (20%) Run-off status (<2 vessels) Tibial anastomosis 219 (46%) 282 (73)% < (15%) 221 (57%) <0.001
17 Comparison with autologous saphenous vein bypass Adjunctive distal procedures HePTFE (476 cases) ASV (385 cases) p No procedure 340 (71%) 357 (92.5%) <0.001 Vein cuff or patching 142 (28%)* 23 (6%) <0.001 Tibial PTA 4 (1%) 4 (1%) - Distal AVF - 1 (0.5%) - *In 63% of patients with tibial anastomosis and in 23% of patients with popliteal anastomosis (p<0.001)
18 Comparison with autologous saphenous vein bypass in CLI Thirty-day results HePTFE (476 cases) ASV (385 cases) p Mortality 9 (1.8%) 3 (0.8%) 0.1 Thrombosis 36 (7.5%) 23 (6%) 0.3 Amputation 18 (3.7%) 8 (2%) 0.1
19 Follow-up Duplex-surveillance program consisted of DUS at 1-12 months and yearly thereafter Median duration of follow-up was 32 months (SD +/-26.4) 848 patients (98.5%) had an available postoperative followup
20 Primary and Secondary Patency of HePTFE graft vs autologous saphenous vein p<0.001; log rank 20.1 p=0.06; log rank 3.8
21 Amputation-free survival and limb salvage of HePTFE graft vs autologous saphenous vein p=0.7; log rank 0.1 p=0.3; log rank 0.9
22 Uni- and multivariate analysis for primary patency in HePTFE group Univariate analysis Multivariate analysis Log-rank p 95% CI OR 95% CI OR p Female gender* Chronic renal failure Reintervention* Diabetes Tibial anastomosis* Distal procedures Run-off score <2* Rutherford 5-6* *Factors affecting limb salvage at univariate analysis
23 Propaten Score CONDITION SCORE CONDITION SCORE CONDITION SCORE Gender Male 1 Female 2 - Reintervention No 1 Yes 2 - Tibial anastomosis No 1 Yes 2 - Run-off score 3 vessel 1 2 vessels 2 1 vessels 3 Rutherford class Class 4 1 Class 5 2 Class 6 3 ANOVA test for thrombosis found as the cut-off score value (p<0.001; R=0.09).
24 Propaten Score for Primary Patency p<0.001; log rank 14.7 p=0.001; log rank 16.8
25 Propaten Patency with score < 7 vs Vein Patency TASC on management of PAD, revision 2007 p=0.6; log rank 0.2
26 Criticisms No randomization was planned and, as a consequence, the two groups differed in several aspects MULTICENTER RANDOMIZED TRIAL OF PROPATEN VASCULAR GRAFT VERSUS AUTOLOGOUS SAPHENOUS VEIN IN BELOW- KNEE REVASCULARIZATION IN PATIENTS WITH CRITICAL LIMB ISCHEMIA UNDER SCRUTINY OF THE ETHICAL COMMITTEE
27 Take home messages
28 Vascular Surgery THANK University of Florence YOU FOR THE KIND ATTENTION!
Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded eptfe graft
From the Society for Vascular Surgery Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded eptfe graft Raffaele Pulli, MD, a Walter
Powerful patency. A decade of performance.
Above-knee Data 1 Year a : 84% N=528 2 Years a : 78% N=320 3 Years a : 76% N=222 Powerful patency. A decade of performance. Below-knee Data 1 Year a : 76% N=745 2 Years a : 67% N=631 3 Years a : 60% N=477
Does heparin impregnated graft improve patency and reduce the cost of lower limb bypass? The REPLACE trial Y. Gouëffic, MD, PhD
Does heparin impregnated graft improve patency and reduce the cost of lower limb bypass? The REPLACE trial Y. Gouëffic, MD, PhD Department of vascular surgery, University hospital of Nantes, France Disclosure
The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions
The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Dr. Sven Bräunlich Department of Angiology University-Hospital Leipzig, Germany Disclosure Speaker
The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Preliminary report
The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Preliminary report G. Biro, M. Bosiers on behalf of ZILVERPASS Study Group Disclosure Speaker
John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division
John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,
Endovascular Should Be Considered First Line Therapy
Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach
Case Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN
Critical Limb Ischemia: A Selective Approach to Revascularization Works Best None Disclosures Michael S. Conte MD, FACS Division of Vascular and Endovascular Surgery Co-Director, Heart and Vascular Center
3-year results of the OLIVE registry:
3-year results of the OLIVE registry: A prospective multicenter study in patients with critical limb ischemia Osamu Iida, MD Kansai Rosai Hospital Cardiovascular Center Amagasaki, Hyogo, Japan Disclosure
Femoropopliteal Above-Knee Bypass: The True Results
Femoropopliteal Above-Knee Bypass: The True Results Lise Pyndt Jørgensen, Camilla Rasmussen & Torben V Schroeder Rigshospitalet and University of Copenhagen, DENMARK Treatment options in the femoropopliteal
Surgical Bypass or. Zilver PTX. 12 months preliminary data. LINC 2016, Leipzig. Marc Bosiers, MD. Marc Bosiers Koen Deloose Joren Callaert
LINC 2016, Leipzig Surgical Bypass or A.Z. Sint-Blasius, Dendermonde Marc Bosiers Koen Deloose Joren Callaert Imelda Hospital, Bonheiden Patrick Peeters Jürgen Verbist Wouter Van den Eynde OLV Hospital,
Lower Extremity Revascularization D oes Anesthesia Matter. Onaona Gurney PGY 4
Lower Extremity Revascularization D oes Anesthesia Matter Onaona Gurney PGY 4 Case Presentation 89yoM PMH of HTN, DM, HLD, BPH presented to podiatry with abscess to R great toe 5 weeks prior Drained by
Disclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009
Disclosures Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach No disclosures No conflicts of interest Christopher D. Owens, MD Objectives Changing face of our patients presenting
Popliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS
Popliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS Asymptomatic mass - 38-40%will develop symptoms at a rate of 14%/yr Intermittent claudic ation (chronic ischemia) - 25%-40%
Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization
Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization A Sonetto, M Abualhin, M Gargiulo, GL Faggioli, A Stella Disclosure Speaker
Olive registry: 3-years outcome of BTK intervention in Japan. Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan
Olive registry: 3-years outcome of BTK intervention in Japan Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan What is the optimal treatment for the patient with critical limb ischemia (CLI)?
4/23/2009. Vein Bypass Remains the Gold Standard AND We Can Improve Outcomes. Lower Extremity Revascularization Options: Key Factors to Consider
Vein Bypass Remains the Gold Standard AND We Can Improve Outcomes Lower Extremity Revascularization Options: Key Factors to Consider General health of the patient Michael S. Conte MD Division of Vascular
Vasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy and Dental Medicine, Arad, Romania
ENDOVASCULAR TREATMENT FOR VASCULAR GRAFT RESTENOSIS Bogdan Totolici 1, Francisca Blanca Călinescu 1*, Ionel Droc 2, Carmen Neamţu 1 1 Vasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy
Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia
Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia Traci A. Kimball, MD Department of Surgery Grand Rounds Septemember 13, 2010 Overview Defining Critical Limb Ischemia Epidemiology
Long-term assessment of cryopreserved vein bypass grafting success
Long-term assessment of cryopreserved vein bypass grafting success Linda Harris, MD, a Monica O Brien-Irr MS, RN, a and John J. Ricotta, MD, b Buffalo, NY Purpose: When autogenous vein is unavailable,
Optimal conduit choice in the absence of singlesegment great saphenous vein for below-knee popliteal bypass
From the Society for Vascular Surgery Optimal conduit choice in the absence of singlesegment great saphenous vein for below-knee popliteal bypass James T. McPhee, MD, Neal R. Barshes, MD, C. Keith Ozaki,
Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?
Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Peter F. Lawrence, M.D. Gonda Vascular Center Division of Vascular Surgery
L uso di protesi biologiche nelle rivascolarizzazioni poplitee
L uso di protesi biologiche nelle rivascolarizzazioni poplitee V. Dorrucci Ospedale dell Angelo - Venice - ITALY Department of Cardio-Thoracic- Vascular Surgery Unit of Vascular and Endovascular Surgery
Real evidence about coatings, cuffs & other measures to improve above knee synthetic graft patency: What is most effective in comparison with vein?
Real evidence about coatings, cuffs & other measures to improve above knee synthetic graft patency: What is most effective in comparison with vein? Devaraj Srinivasamurthy ESVB 2013 Introduction Significant
Distal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff
Distal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff P. Kuryanov, A. Lipin, A. Antropov, K. Atmadzas, A. Atmadzas, Y. Eminov, A. Borisov, R. Sobolev, A.Orlov Limb
Accurate Vessel Sizing Drives Clinical Results. IVUS In the Periphery
Accurate Vessel Sizing Drives Clinical Results IVUS In the Periphery Discussion Iida O, et. al. Study Efficacy of Intravascular Ultrasound in Femoropopliteal Stenting for Peripheral Artery Disease With
Heparin-bonded eptfe grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results
Heparin-bonded eptfe grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results Kim Daenens, MD, Stijn Schepers, MD, Inge Fourneau, MD, PhD, Sabrina Houthoofd,
Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are
An initial strategy of open bypass is better for some CLI patients, and we can define who they are Fadi Saab, MD, FASE, FACC, FSCAI Metro Heart & Vascular Metro Health Hospital, Wyoming, MI Assistant Clinical
Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012
Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? Easy 89 yo Non-ambulatory Multiple failed interventions Forefoot and heel gangrene Andres Schanzer, MD
4/14/2016. How Far Should We Go with the Endovascular Treatment of Advanced PAD in the Era of Health Care Reform?
FINANCIAL DISCLOSURE How Far Should We Go with the Endovascular Treatment of Advanced PAD in the Era of Health Care Reform? An Endocompetent Vascular Surgeon s View Bruce A. Perler, MD, MBA I Have No Financial
Popliteal Artery Aneurysms: Diagnosis and Repair Options
Deepak N. Deshmukh DO April 27, 2018 Popliteal Artery Aneurysms: Diagnosis and Repair Options No Disclosures Popliteal Artery Aneurysms (PAAs) Male Predominanace Most common peripheral Aneurysm (70%) 30-50%
Paclitaxel-coated versus Plain Balloon Angioplasty in the Treatment of Infrainguinal Vein Bypass Stenosis
Paclitaxel-coated versus Plain Balloon Angioplasty in the Treatment of Infrainguinal Vein Bypass Stenosis T. Hölzenbein, A. Ugurluoglu, M. Aspalter, W. Hitzl, K. Linni Dep Vascular & Endovascular Surgery
LIMB SALVAGE IN THE DIABETIC PATIENT
LIMB SALVAGE IN THE DIABETIC PATIENT WHO? HOW? BEST? DISCLOSURES Educational grant from Cook Inc OBJECTIVES Review risk stratification and staging schemes for the threatened limb Discuss current concepts
Remote Endarterectomy Update
Remote Endarterectomy Update An endovascular alternative to bypass? BY JOHN D. MARTIN, MD Treating the superficial femoral artery (SFA) is still one of the most highly debated topics among vascular specialists.
Endovascular treatment (EVT) has markedly advanced,
Ann Vasc Dis Vol. 6, No. 3; 2013; pp 573 577 Online August 12, 2013 2013 Annals of Vascular Diseases doi:10.3400/avd.oa.13-00055 Original Article A Review of Surgically Treated Patients with Obstruction
Comparison of propaten heparin-bonded vascular graft with distal anastomotic patch versus autogenous saphenous vein graft in tibial artery bypass
Original Article Comparison of propaten heparin-bonded vascular graft with distal anastomotic patch versus autogenous saphenous vein graft in tibial artery bypass Vascular 0(0) 1 9! The Author(s) 2017
Distal By-Pass procedures can reduce limb loss
Conventional treatment of the diabetic foot Distal By-Pass procedures can reduce limb loss Dr. Nikolaos Melas, PhD Vascular and Endovascular Surgeon Military Doctor Associate in 1st department of Surgery,
The influence of the characteristics of ischemic tissue lesions on ulcer healing time after infrainguinal bypass for critical leg ischemia
The influence of the characteristics of ischemic tissue lesions on ulcer healing time after infrainguinal bypass for critical leg ischemia Maria Söderström, MD, Pekka-Sakari Aho, MD, PhD, Mauri Lepäntalo,
Ten Years of Experience with the Heparin-Bonded eptfe Graft The Newest Advancement in Vascular Surgery
Supplement to the September/October 2010 TM, LLC M A N A G E M E N T Ten Years of Experience with the Heparin-Bonded eptfe Graft The Newest Advancement in Vascular Surgery This activity is supported by
Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results
Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results Marc Bosiers, MD, a Koen Deloose, MD, a Jürgen Verbist, MD, b Herman
Surgical Bypass vs. Zilver PTX stent for long SFA lesions : Interim results of the ZilverPass Trial
Surgical Bypass vs. Zilver PTX stent for long SFA lesions : Interim results of the ZilverPass Trial Dr. Koen Deloose Head of Vascular Surgery AZ Sint-Blasius Dendermonde Belgium Disclosure slide Speaker
The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio
The present status of selfexpanding and balloonexpandable tibial BMS and DES for CLI: Why and when to use Sean P Lyden MD Cleveland Clinic Cleveland, Ohio Disclosure Speaker name: Sean Lyden, MD I have
Lower Extremity Peripheral Arterial Disease: Its All About the Pulse. Spence M Taylor, M.D.
Lower Extremity Peripheral Arterial Disease: Its All About the Pulse Spence M Taylor, M.D. President, Greenville Health System Clinical University Senior Associate Dean for Academic Affairs and Diversity
Surgical Options for revascularisation P E T E R S U B R A M A N I A M
Surgical Options for revascularisation P E T E R S U B R A M A N I A M The goal Treat pain Heal ulcer Preserve limb Preserve life The options Conservative Endovascular Surgical bypass Primary amputation
Comparison of long-term results of above-the-knee femoro-popliteal bypass with autogenous vein and polytetrafluoroethylene grafts
ORIGINAL ARTICLE pissn 2288-6575 eissn 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.1.28 Annals of Surgical Treatment and Research Comparison of long-term results of above-the-knee femoro-popliteal
Percutaneous Angioplasty for Infrainguinal Graft-related Stenoses
Eur J Vasc Endovasc Surg 14, 380-385 (1997) Percutaneous Angioplasty for Infrainguinal Graft-related Stenoses A. D. Houghton ~1, C. Todd 1, B. Pardy 2, P. R. Taylor ~ and J. F. Reidy ~ Departments of Surgery,
DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes
DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes Carlos Mena, MD FACC FSCAI Associate Professor of Medicine - Cardiology Director Cardiac
Critical Limb Ischemia: Diagnosis and Current Management
Research Article Joseph Karam, MD Elliot J. Stephenson, MD From: Minneapolis Heart Institutet at Abbott Northwestern Hospital, Minneapolis, MN Address for correspondence: Joseph Karam, MD Minneapolis Heart
Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia
Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia Albeir Mousa, MD., FACS.,MPH., MBA Professor of Vascular and Endovascular Surgery West Virginia University Disclosure None What you
Evidence-Based Optimal Treatment for SFA Disease
Evidence-Based Optimal Treatment for SFA Disease Endo first Don t burn surgical bridge Don t stent if possible Javairiah Fatima, MD Assistant Professor of Surgery Division of Vascular and Endovascular
Arthroplasty after previous surgery: previous vascular problems
Arthroplasty after previous surgery: previous vascular problems Jacques Menetrey & Victoria B. Duthon Centre de médecine de l appareil locomoteur et du sport Swiss Olympic medical Center Unité d Orthopédie
Clinical presentation and outcome after failed infrainguinal endovascular and open revascularization in patients with chronic limb ischemia
From the Society for Clinical Vascular Surgery Clinical presentation and outcome after failed infrainguinal endovascular and open revascularization in patients with chronic limb ischemia Hasan H. Dosluoglu,
SPINACH Making Limb Salvage Salad from Spinach alone
SPINACH Making Limb Salvage Salad from Spinach alone Surgical reconstruction versus Peripheral Intervention in patients with critical limb ischemia prospective multicenter registry in Japan Nobuyoshi Azuma,
Polytetrafluoroethylene (PTFE) Femorodistal Grafts with a Distal Vein Cuff for Critical Ischaemia
Eur J Vasc Endovasc Surg 15, 449-453 (1998) Polytetrafluoroethylene (PTFE) Femorodistal Grafts with a Distal Vein Cuff for Critical Ischaemia L. D. Wijesinghe ~, D, M. Beardsmore and D, J. A. Scott Department
Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis
Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis Osamu Iida, MD From the Kansai Rosai Hospital Cardiovascular Center, Amagasaki City, Japan. ABSTRACT: Approximately
Forget about the angiosome theories. Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France
Forget about the angiosome theories Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France Disclosure of Interest Research grants /Consulting/Honoraria for - Abbott -
Comparing endoluminal bypass to open fem-pop bypasses; Final 1-year results of the SUPERB trial
Comparing endoluminal bypass to open fem-pop bypasses; Final 1-year results of the SUPERB trial Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands Disclosure Speaker name: Michel Reijnen I have
Popliteal Bypass Versus Percutaneous Transluminal
501591SJS102410.1177/1457496913501591The treatment of occlusive superficial femoral artery diseaseh. Linnakoski, et al. 2013 ORIGINAL ARTICLE Scandinavian Journal of Surgery 102: 227 233, 2013 Comparison
Long-term Results of Above Knee Femoro-popliteal Bypass Depend on Indication for Surgery and Graft-material
Eur J Vasc Endovasc Surg 29, 412 418 (2005) doi:10.1016/j.ejvs.2004.12.023, available online at http://www.sciencedirect.com on Long-term Results of Above Knee Femoro-popliteal Bypass Depend on Indication
Are RCT always needed: Experience with objective performance criteria (OPC)
Are RCT always needed: Experience with objective performance criteria (OPC) Peter A. Schneider, MD Krishna Rocha-Singh, MD Kaiser Foundation Hospital Honolulu, Hawaii Prarie Heart Institute Springfield,
DCB in my practice: How the evidence influences my strategy. Yang-Jin Park
DCB in my practice: How the evidence influences my strategy Yang-Jin Park Associate Professor Division of Vascular Surgery, Department of Surgery Samsung Medical Center Sungkyunkwan University School of
Comparing vein with collagen impregnated woven polyester prosthesis in above-knee femoropopliteal bypass grafting
International Journal of Surgery (2007) 5, 109e113 www.theijs.com Comparing vein with collagen impregnated woven polyester prosthesis in above-knee femoropopliteal bypass grafting A. Mohammadi Tofigh a,
Pedal Bypass With Deep Venous Arterialization:
Pedal Bypass With Deep Venous Arterialization: Long Term Result For Critical Limb Ischemia With Unreconstructable Distal Arteries Pramook Mutirangura Professor of Vascular Surgery Faculty of Medicine Siriraj
The Society for Vascular Surgery s. Objective Performance Goals for Lower Extremity Revascularization
The Society for Vascular Surgery s Objective Performance Goals for Lower Extremity Revascularization Are Not Generalizable to Many Open Surgical Bypass Patients Encountered in Contemporary Surgical Practice
Practical Point in Holistic Diabetic Foot Care 3 March 2016
Diabetic Foot Ulcer : Vascular Management Practical Point in Holistic Diabetic Foot Care 3 March 2016 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai
BEST-CLI Trial Study Concept and Current Status
BEST-CLI Trial Study Concept and Current Status Kenneth Rosenfield, MD, MHCDS National Co-PI BEST-CLI Trial Section Head, Vascular Medicine and Intervention Institute for Heart, Vascular, and Stroke Care
A Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts. Avishai Meyer UCHSC resident, Surgery May 8, 2006
A Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts Avishai Meyer UCHSC resident, Surgery May 8, 2006 Outline: Definition Background of terms and studies U/S surveillance What
BIOLUX P-III Passeo-18 Lux All-comers Registry: 12-month Results for the All-Comers Cohort
BIOLUX P-III Passeo-18 Lux All-comers Registry: 12-month Results for the All-Comers Cohort Prof. Dr. Gunnar TEPE, Klinikum Rosenheim, Germany CCI on behalf of the BIOLUX P-III Investigators Disclosure
Influence of vein size (diameter) on infrapopliteal reversed vein graft patency
Influence of vein size (diameter) on infrapopliteal reversed vein graft patency Kurt R. Wengerter, MD, Frank J. Veith, MD, Sushil K. Gupta, MD, Enrico Ascer, MD, and Steven P. Rivers, MD, New York, N.Y.
Femoropopliteal Balloon Angioplasty vs. Bypass Surgery for CLI: A Propensity Score Analysis
Eur J Vasc Endovasc Surg (), 78e8 Femoropopliteal Balloon vs. Bypass Surgery for CLI: A Propensity Score Analysis M. Korhonen a,b, *, F. Biancari c,m.söderström a, E. Arvela a, K. Halmesmäki a, A. Albäck
Hybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results.
Hybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results. Wronski J. 1), 2) 3), Wilczynski M 1), Gembal P 1), Milik K 1), Dec St 1), Grybos
Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview
Tips and Tricks for Tibial Intervention Donald L. Jacobs, MD C Rollins Hanlon Endowed Professor and Chair Chair of Surgery Saint Louis University SSM-STL Saint Louis University Hospital Disclosures Abbott
Resource utilization in the treatment of critical limb ischemia: the effect of tissue loss, comorbidities, and graft-related events
From the Society for Clinical Vascular Surgery Resource utilization in the treatment of critical limb ischemia: the effect of tissue loss, comorbidities, and graft-related events Louis L. Nguyen, MD, MBA,
Angiosome revascularization strategies in real world practice: how much difference does it make?
Angiosome revascularization strategies in real world practice: how much difference does it make? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Disclosure Peter A. Schneider... I have
Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention
In-Stent Restenosis: The Tail IS Wagging the Dog Disclosures NONE Michael S. Conte MD Division of Vascular and Endovascular Surgery UCSF Heart and Vascular Center UCSF Vascular Symposium 2016 IF YOU WERE
Multidisciplinary approach to BTK Y. Gouëffic, MD, PhD
Multidisciplinary approach to BTK Y. Gouëffic, MD, PhD Department of vascular surgery, University Hospital of Nantes, France Response to the increased demand of hospital care Population is aging Diabetes
Disclosures. Carotid artery stenting. Surveillance after Endovascular Intervention: When to Re-Intervene and What s the Evidence
Disclosures Surveillance after Endovascular Intervention: When to Re-Intervene and What s the Evidence None 2015 UCSF Vascular Symposium Warren Gasper, MD Assistant Professor of Surgery UCSF Division of
Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry
Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry Marianne Brodmann, MD Head of the Clinical Division of Angiology Department of Internal Medicine Medical University
CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS
CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS CRITICAL LIMB ISCHEMIA... 1 CONCLUSION... 9 U.S. CRITICAL LIMB ISCHEMIA PREVALENCE... 9 MARKET OPPORTUNITY ENDOVASCULAR... 9 MARKET OPPORTUNITY
Long-Term Results of Treatment for Critical Limb Ischemia
2015 Annals of Vascular Diseases doi:10.3400/avd.oa.15-00074 Original Article Long-Term Results of Treatment for Critical Limb Ischemia Takuya Miyahara, MD, PhD, 1 Masamitsu Suhara, MD, 1 Yoko Nemoto,
Peripheral Vascular Disease
Peripheral artery disease (PAD) results from the buildup of plaque (atherosclerosis) in the arteries of the legs. For people with PAD, symptoms may be mild, requiring no treatment except modification of
Disclosures: Stent-grafts for Long-Segment SFA Disease: Better than the Alternatives? SFA Treatment Overview: Longer Lesions 4/18/2013
Stent-grafts for Long-Segment SFA Disease: Better than the Alternatives? Richard Saxon MD Director of Research San Diego Cardiac and Vascular Institute San Diego Imaging Medical Group San Diego, CA Disclosures:
A randomized comparison of endovascular versus surgery treatment of common femoral artery disease: Results from the TECCO trial
A randomized comparison of endovascular versus surgery treatment of common femoral artery disease: Results from the TECCO trial (TECCO randomized clinical trial, NCT01353651) Y. Gouëffic, N. Della Schiava,
Is stenting a safe and durable option in the common femoral artery?
Is stenting a safe and durable option in the common femoral artery? (TECCO randomized clinical trial, NCT01353651) Y. Gouëffic, N. Della Schiava, F. Thaveau, E. Rosset, J.P. Favre, L. Salomon du Mont,
Update from Korea on the Lutonix SFA registry 12 month data
Update from Korea on the Lutonix SFA registry 12 month data Prospective, Multicenter, Post-Market Registy Assessing the Clinical Use and Safety of the Lutonix Drug Coated Balloon in Femoropopliteal Arteries
Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines
Recommendations for Follow-up After Vascular Surgery Arterial Procedures 2018 SVS Practice Guidelines vsweb.org/svsguidelines About the guidelines Published in the July 2018 issue of Journal of Vascular
Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)
Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,
Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort
Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort a.o. Univ. Prof. Dr. Marianne Brodmann Medical University of Graz Graz,
PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014
PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 Van Crisco, MD, FACC, FSCAI First Coast Heart and Vascular Center, PLLC Jacksonville, FL 678-313-6695 Conflict of Interest Bayer Healthcare
Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC
Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton,
Interventional Treatment First for CLI
Interventional Treatment First for CLI Patrick Alexander, MD, FACC, FSCAI Interventional Cardiology Medical Director, Critical Limb Clinic Providence Heart Institute, Southfield MI 48075 Disclosures Consultant
PUT YOUR BEST FOOT FORWARD
PUT YOUR BEST FOOT FORWARD Bala Ramanan, MBBS 1 st year vascular surgery fellow Introduction The epidemic of diabetes and ageing of our population ensures critical limb ischemia will continue to grow.
Clinical Data Update for Drug Coated Balloons (DCB) Seung-Whan Lee, MD, PhD
Clinical Data Update for Drug Coated Balloons (DCB) Seung-Whan Lee, MD, PhD Asan Medical Center, Heart Institute, University of Ulsan College of Medicine, Werk et al. Circulation Cardiovasc Intervent 2012
pat hways Medtech innovation briefing Published: 21 July 2015 nice.org.uk/guidance/mib34
pat hways Spiral Flow peripheral vascular graft for treating peripheral arterial disease Medtech innovation briefing Published: 21 July 2015 nice.org.uk/guidance/mib34 Summary The Spiral Flow peripheral
Hiroshi Ando, MD Kasukabe Chuo General Hospital Saitama, Japan
Hiroshi Ando, MD Kasukabe Chuo General Hospital Saitama, Japan Disclosure Hiroshi Ando, MD Kasukabe Chuo General Hospital I have the following potential conflicts of interest to report: Consulting Employment
Long-term outcomes of infrainguinal bypass surgery for patients with diabetes mellitus and tissue loss
ORIGINAL ARTICLE pissn 2288-6575 eissn 2288-6796 http://dx.doi.org/1174/astr.215.88.1.35 Annals of Surgical Treatment and Research Long-term outcomes of infrainguinal bypass surgery for patients with diabetes